SurgiCal Obesity Treatment Study

Recruitment status:
Recruiting
Primary Sponsor:
NHS Greater Glasgow and Clyde (UK)
Recruitment countries:
United Kingdom
Health condition studied:
Obesity
Nutritional, Metabolic, Endocrine
Obesity
URL:
Link to the clinical trial website

About the trial

Interventions:
Bariatric surgery (surgical procedures developed for the primary purpose of weight loss currently laparoscopic gastric banding, sleeve gastrectomy and roux-en-y gastric bypass)

2000 patients undergoing bariatric surgery in the NHS and private sector in Scotland, UK, over a 5 year period will be recruited. The participants will be followed up for a mean of 10 years. The mortality, weight, incident type 2 diabetes mellitus (T2DM), coronary heart disease (CHD), cardiovascular disease (CVD), cancer, fractures, nutritional blood markers, anxiety, depression, post-operative complications, revisional surgery rates, health related quality of life, glycaemic control, diabetic complications and diabetes medications will be recorded.
Key inclusion and exclusion criteria:
  • Inclusion criteria: Undergoing bariatric surgery in NHS secondary care and private practice in Scotland, UK
  • Exclusion criteria: Does not meet inclusion criteria
  • Age minimum:
  • Age maximum:
  • Gender: Both
Primary outcomes:
10 year mortality
Secondary outcomes:
In the 10 years following bariatric surgery:
1. Change in weight / body mass index (BMI) from pre-bariatric surgery weight
2. Rate of incident type 2 diabetes
3. Incidence of fatal and non-fatal coronary heart disease, cardiovascular disease, cancer and fractures
4. Incidence of incidence of nutritional deficiencies
5. Change in incidence of depression and anxiety compared to baseline level pre-operatively
6. Incidence of complications immediately post-operatively and the need for readmission for revisional procedures
7. Change in health-related quality of life compared to baseline level pre-operatively
8. Change in glycaemic control, cardiovascular risk factors, chronic kidney disease (CKD), retinopathy and medications prescribed in patients with diabetes compared to equally obese patient with diabetes who did not have bariatric surgery
9. Cost of the procedure and follow-up (to inform cost-effectiveness analysis)
Target sample size:
2000
Study type:
Observational
Study design:
Multi-centre prospective cohort study (Quality of life)
Contacts:
  • Name:
  • Address:
  • Phone:
  • Email:
  • Affiliation:
  • Name: Jennifer Logue
  • Address: BHF Cardiovascular Research Centre University of Glasgow 126 University Place
  • Phone:
  • Email:
  • Affiliation:

Technical details

Scientific title:
SurgiCal Obesity Treatment Study: a prospective cohort study
Sources of monetary support:
NIHR Health Technology Assessment Programme - HTA (UK) (10/42/02)
Secondary sponsors:
Main ID:
ISRCTN47072588
Secondary ID:
HTA: 10/42/02
Register:
ISRCTN
Date of registration:
30/09/2024
Date of first enrollment:
01/01/2025
Last refreshed:
13 January 2025

Disclaimer

Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record

Back to clinical trials list